Found: 10
Select item for more details and to access through your institution.
Characterization of the Secretome of a Specific Cell Expressing Mutant Methionyl-tRNA Synthetase in Co-Culture Using Click Chemistry.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 12, p. 6527, doi. 10.3390/ijms23126527
- By:
- Publication type:
- Article
Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma.
- Published in:
- Experimental & Molecular Medicine EMM, 2024, v. 56, n. 9, p. 2082, doi. 10.1038/s12276-024-01320-0
- By:
- Publication type:
- Article
Naa12 compensates for Naa10 in mice in the amino-terminal acetylation pathway.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.65952
- By:
- Publication type:
- Article
Streamlined selection of cancer antigens for vaccine development through integrative multi-omics and high-content cell imaging.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-62244-z
- By:
- Publication type:
- Article
Multiplexed plasma protein classifiers for the diagnosis of age‐related macular degeneration.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 6, p. 1, doi. 10.1002/ctm2.1307
- By:
- Publication type:
- Article
Correction to: R-catcher, a potent molecular tool to unveil the arginylome.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
R-catcher, a potent molecular tool to unveil the arginylome.
- Published in:
- Cellular & Molecular Life Sciences, 2021, v. 78, n. 7, p. 3725, doi. 10.1007/s00018-021-03805-x
- By:
- Publication type:
- Article
Glioblastoma-secreted soluble CD44 activates tau pathology in the brain.
- Published in:
- Experimental & Molecular Medicine EMM, 2018, v. 50, n. 4, p. 1, doi. 10.1038/s12276-017-0008-7
- By:
- Publication type:
- Article
Glioblastoma-secreted soluble CD44 activates tau pathology in the brain.
- Published in:
- Experimental & Molecular Medicine EMM, 2018, v. 50, n. 4, p. 1, doi. 10.1038/s12276-017-0008-7
- By:
- Publication type:
- Article
Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17139-y
- By:
- Publication type:
- Article